Navigation Links
Dr. Samuel Henderson, Accera's V.P. of Research and Development, to Present at the 249th American Chemical Society National Meeting

BROOMFIELD, Colo., Feb. 20, 2015 /PRNewswire/ -- Accera, Inc, a leader in the development of new therapies to treat neurological disorders, today announced that Dr. Samuel Henderson, Accera's Vice President of Research and Development, will present a review of the company's technology at the 249th American Chemical Society National Meeting that will be held in Denver, Colorado, March 22-26, 2015.

The presentation entitled, "Induced ketosis in mild to moderate Alzheimer's disease" will take place in the Colorado Biotechnology Session at 10:10-10:50am on Sunday, March 22nd in the Mt. Sopris Room at the Grand Hyatt Denver.

About Accera

Accera is a privately held biotechnology company focused on the development of therapies for central nervous system disorders. Accera's proprietary scientific platform includes breakthrough discoveries focused on addressing brain health and Alzheimer's disease. Accera is leveraging the latest scientific knowledge and understanding of neurological disorders to develop therapies intended to address Alzheimer's disease and other neurological disorders. Accera has world-leading capabilities in clinical development for Alzheimer's disease and applies these strengths to its novel pipeline. The company is developing a pipeline of innovative products targeting several neurodegenerative conditions. Our lead product candidate, AC-1204, a first-in-class ketosis-inducing compound, is being studied in patients with Alzheimer's disease.

Courtney Settle
Accera, Inc.
Tel: 303.999.3700


SOURCE Accera, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Samuel Pang, MD and Isaac Glatstein, MD of the Reproductive Science Center of New England, Rated Top Docs in Infertility Diagnosis and Treatment by Boston Magazine
2. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
3. Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
4. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
5. Guiding responsible research in geoengineering
6. Research Team led by JCVI Scientists Uncover More Complexity and Detail in Southern African Genomic Diversity
7. Probiotic Action Explains New Research that Probiotics Help Reduce Stress Side Effects
8. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
9. Recent Research Shows Benefits of Chiropractic Care for Infantile Colic
10. Global Bio-implants Market 2012-2016 New Research Report Now Available at
11. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
Post Your Comments:
(Date:7/17/2019)... ... July 15, 2019 , ... CRISPR is often thought of as ... can be removed, replaced, or edited, but Yiping Qi, assistant professor in Plant Science ... applications in his latest publication in Nature Plants. In this comprehensive review, Qi and ...
(Date:7/9/2019)... ... July 08, 2019 , ... ... SmartLight Indicator was recognized as the 2019 Innovative Product of the Year which ... prestigious awards were during Sensors Expo & Conference 2019, held this ...
(Date:6/12/2019)... (PRWEB) , ... June 12, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... Zillion has been signed. The agreement will grant exclusive rights for Zillion to ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
Breaking Biology Technology:
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
(Date:7/10/2019)... ... 2019 , ... Inference Solutions , a global provider ... its role in Pizza Hut Australia’s digital transformation initiative to improve ... part of this initiative is implementation of an automated call-steering application that uses ...
(Date:7/5/2019)... MOUNTAIN VIEW, Calif. (PRWEB) , ... July 05, ... ... is partnering with Microsoft to bring its patented Tractus™ Platform to governments around ... solution will bring cutting edge technology and point of care solutions to operating ...
Breaking Biology News(10 mins):